Genetics of caffeine consumption and responses to caffeine

Psychopharmacology

Volumn 211, Issue 3, 2010, Pages 245-257

  Yang, Amy ^a   Palmer, Abraham A ^a   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adenosine; Caffeine; CYP1A2; Dopamine; Genetic polymorphism; Parkinson's cardiovascular disease

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; CAFFEINE; CALCIUM CHANNEL; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A2; DOPAMINE 2 RECEPTOR; ADENOSINE RECEPTOR; DOPAMINE RECEPTOR;

ACETYLCHOLINE RELEASE; ANXIETY DISORDER; CARDIOVASCULAR DISEASE; COFFEE; COMPETITIVE INHIBITION; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; FOOD PREFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HERITABILITY; HUMAN; INSOMNIA; NEUROPROTECTION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; WITHDRAWAL SYNDROME; ANIMAL; CHEMICALLY INDUCED; DRINKING BEHAVIOR; DRUG EFFECTS; GENETICS; PHYSIOLOGY; TWINS;

ANIMALS; CAFFEINE; CARDIOVASCULAR DISEASES; CYTOCHROME P-450 CYP1A2; DRINKING BEHAVIOR; HUMANS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE; RECEPTORS, PURINERGIC P1; TWIN STUDIES AS TOPIC;

EID: 77955466657     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1900-1     Document Type: Review

References (114)

1. J Abraham JO Mudd N Kapur K Klein HC Champion IS Wittstein 2009 Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists J Am Coll Cardiol 53 1320 1325 1:CAS:528: DC%2BD1MXktlyqtLc%3D 19358948
2. K Alsene J Deckert P Sand H de Wit 2003 Association between A2a receptor gene polymorphisms and caffeine-induced anxiety Neuropsychopharmacology 28 1694 1702 1:CAS:528:DC%2BD3sXmsFeisLo%3D 12825092
3. LF Andersen DR Jacobs Jr MH Carlsen R Blomhoff 2006 Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study Am J Clin Nutr 83 1039 1046 1:CAS:528:DC%2BD28XkvFOrsLk%3D 16685044
4. F Arias Horcajadas S Sánchez Romero J Padìn Calo S Fernández-Rojo G Fernández Martìn 2005 Psychoactive drugs use in patients with panic disorder Actas Esp Psiquiatr 33 160 164 1:STN:280:DC%2BD2M3ntlOluw%3D%3D 15918083
5. MJ Arnaud 1987 The pharmacology of caffeine Prog Drug Res 31 273 313 1:CAS:528:DyaL1cXhtVGkurc%3D 3326033
6. A Ascherio SM Zhang MA Hernán I Kawachi GA Colditz FE Speizer WC Willett 2001 Prospective study of caffeine consumption and risk of Parkinson's disease in men and women Ann Neurol 50 56 63 1:CAS:528:DC%2BD3MXlt12gurg%3D 11456310
7. F Bchir M Dogui R Ben Fradj MJ Arnaud S Saguem 2006 Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects CR Biol 329 512 519 1:CAS:528:DC%2BD28XmtVOjuro%3D
8. NL Benowitz 1990 Clinical pharmacology of caffeine Annu Rev Med 41 277 288 1:CAS:528:DyaK3cXktVSjs74%3D 2184730
9. F Berthou T Goasduff Y Dréano J-F Ménez 1995 Caffeine increases its own metabolism through cytochrome P4501A induction in rats Life Sci 57 541 549 1:CAS:528:DyaK2MXms1ahurs%3D 7623622
10. JP Boulenger J Patel RM Post AM Parma PJ Marangos 1983 Chronic caffeine consumption increases the number of brain adenosine receptors Life Sci 32 1135 1142 1:CAS:528:DyaL3sXhtF2mtb0%3D 6298543
11. M Bruce N Scott P Shine M Lader 1992 Anxiogenic effects of caffeine in patients with anxiety disorders Arch Gen Psychiatry 49 867 869 1:STN:280:DyaK3s%2FnsVarsw%3D%3D 1444724
12. D Carmelli GE Swan D Robinette RR Fabsitz 1990 Heritability of substance use in the NAS-NRC Twin Registry Acta Genet Med Gemellol (Roma) 39 91 98 1:STN:280:DyaK3czmsVyisA%3D%3D
13. AJ Carter WT O'Connor MJ Carter U Ungerstedt 1995 Caffeine enhances acetylcholine release in the hippocampus in vivo by a selective interaction with adenosine A1 receptors J Pharmacol Exp Ther 273 637 642 1:CAS:528: DyaK2MXlslantbs%3D 7752065
14. O Cauli M Morelli 2005 Caffeine and the dopaminergic system Behav Pharmacol 16 63 77 1:CAS:528:DC%2BD2MXit1OntLc%3D 15767841
15. DS Charney GR Heninger PI Jatlow 1985 Increased anxiogenic effects of caffeine in panic disorders Arch Gen Psychiatry 42 233 243 1:CAS:528: DyaL2MXitFCqtLc%3D 2983630
16. H Checkoway K Powers T Smith-Weller GM Franklin WT Longstreth Jr PD Swanson 2002 Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake Am J Epidemiol 155 732 738 11943691
17. J-F Chen K Xu JP Petzer R Staal Y-H Xu M Beilstein PK Sonsalla K Castagnoli N Castagnoli Jr MA Schwarzschild 2001 Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease J Neurosci 21 143RC
18. E Childs C Hohoff J Deckert K Xu J Badner H de Wit 2008 Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety Neuropsychopharmacology 33 2791 2800 1:CAS:528:DC%2BD1cXht1CmsL7M 18305461
19. F Ciruela V Casado RJ Rodrigues R Lujan J Burgueno M Canals J Borycz N Rebola SR Goldberg J Mallol A Cortes EI Canela JF Lopez-Gimenez G Milligan C Lluis RA Cunha S Ferre R Franco 2006 Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers J Neurosci 26 2080 2087 1:CAS:528:DC%2BD28XitVansbo%3D 16481441
20. MC Cornelis A El-Sohemy EK Kabagambe H Campos 2006 Coffee, CYP1A2 genotype, and risk of myocardial infarction JAMA 295 1135 1141 1:CAS:528:DC%2BD28XitV2htr0%3D 16522833
21. MC Cornelis A El-Sohemy H Campos 2007 Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption Am J Clin Nutr 86 240 244 1:CAS:528:DC%2BD2sXotVynurs%3D 17616786
22. JW Daly BB Fredholm 1998 Caffeine-an atypical drug of dependence Drug Alcohol Depend 51 199 206 1:CAS:528:DyaK1cXks1Olsbc%3D 9716941
23. JW Daly P Buttslamb W Padgett 1983 Subclasses of adenosine receptors in the central nervous-system-interaction with caffeine and related methylxanthines Cell Mol Neurobiol 3 69 80 1:CAS:528:DyaL3sXkvVantbs%3D 6309393
24. J Deckert MM Nothen P Franke C Delmo J Fritze M Knapp W Maier H Beckmann P Propping 1998 Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease Mol Psychiatry 3 81 85 1:CAS:528:DC%2BD3cXls1Gls7c%3D 9491818
25. HW Devonshire I Kong M Cooper TP Sloan JR Idle RL Smith 1983 The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition Br J Clin Pharmacol 16 157 166 1:CAS:528:DyaL3sXkvFyku7w%3D 6615690
26. CM Dhaenens S Burnouf C Simonin E Van Brussel A Duhamel L Defebvre C Duru I Vuillaume C Cazeneuve P Charles P Maison S Debruxelles C Verny H Gervais JP Azulay C Tranchant AC Bachoud-Levi A Durr L Buee P Krystkowiak B Sablonniere D Blum 2009 A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease Neurobiol Dis 35 474 476 1:CAS:528:DC%2BD1MXpsFylsL4%3D 19591938
27. TV Dunwiddie SA Masino 2001 The role and regulation of adenosine in the central nervous system Annu Rev Neurosci 24 31 55 1:CAS:528:DC%2BD3MXls1Siu7c%3D 11283304
28. M El Yacoubi C Ledent M Parmentier J Costentin J-M Vaugeois 2005 Reduced appetite for caffeine in adenosine A2A receptor knockout mice Eur J Pharmacol 519 290 291 1:CAS:528:DC%2BD2MXhtVSmsb%2FP 16129427
29. S Evans R Griffiths 1992 Caffeine tolerance and choice in humans Psychopharmacology 108 51 59 1:CAS:528:DyaK38XkvVegsL8%3D 1410146
30. MF Facheris NK Schneider TG Lesnick A Md JM Cunningham WA Rocca DM Maraganore 2008 Coffee, caffeine-related genes, and Parkinson's disease: a case-control study Mov Disord 23 2033 2040 18759349
31. NH Farag AS Vincent BS McKey TL Whitsett WR Lovallo 2005 Hemodynamic mechanisms underlying the incomplete tolerance to caffeine's pressor effects Am J Cardiol 95 1389 1392 1:CAS:528:DC%2BD2MXkt1ant7Y%3D 15904654
32. S Fenu O Cauli M Morelli 2000 Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors Behav Brain Res 114 97 105 1:CAS:528:DC%2BD3cXmtlGkuro%3D 10996051
33. S Ferre 2008 An update on the mechanisms of the psychostimulant effects of caffeine J Neurochem 105 1067 1079 1:CAS:528:DC%2BD1cXmsVOlsro%3D 18088379
34. JS Fink DR Weaver SA Rivkees RA Peterfreund AE Pollack EM Adler SM Reppert 1992 Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum Brain Res Mol Brain Res 14 186 195 1:CAS:528:DyaK3sXhvVelt7o%3D 1279342
35. G Fisone A Borgkvist A Usiello 2004 Caffeine as a psychomotor stimulant: mechanism of action Cell Mol Life Sci 61 857 872 1:CAS:528:DC%2BD2cXls1Grt7k%3D 15095008
36. CD Frary RK Johnson MQ Wang 2005 Food sources and intakes of caffeine in the diets of persons in the United States J Am Diet Assoc 105 110 113 15635355
37. BB Fredholm K Bättig J Holmén A Nehlig EE Zvartau 1999 Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 83 133 1:CAS:528: DyaK1MXitFWgurk%3D 10049999
38. K Fuxe LF Agnati K Jacobsen J Hillion M Canals M Torvinen B Tinner-Staines W Staines D Rosin A Terasmaa P Popoli G Leo V Vergoni C Lluis F Ciruela R Franco S Ferre 2003 Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease Neurology 61 19S 23S
39. BE Garrett RR Griffiths 1997 The role of dopamine in the behavioral effects of caffeine in animals and humans Pharmacol Biochem Behav 57 533 541 1:CAS:528:DyaK2sXkt1yhsr0%3D 9218278
40. RR Griffiths PP Woodson 1988 Reinforcing effects of caffeine in humans J Pharmacol Exp Ther 246 21 29 1:CAS:528:DyaL1cXltVClsLg%3D 3392652
41. LM Grosso MB Bracken 2005 Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy Ann Epidemiol 15 460 466 15967394
42. A Gunes ML Dahl 2008 Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms Pharmacogenomics 9 625 637 1:CAS:528:DC%2BD1cXlvFyisr8%3D 18466106
43. SP Hamilton SL Slager AB De Leon GA Heiman DF Klein SE Hodge MM Weissman AJ Fyer JA Knowles 2004 Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder Neuropsychopharmacology 29 558 565 1:CAS:528:DC%2BD2cXhtlWksb4%3D 14666117
44. JL Hansen DR Reed MJ Wright NG Martin PA Breslin 2006 Heritability and genetic covariation of sensitivity to PROP, SOA, quinine HCl, and caffeine Chem Senses 31 403 413 1:CAS:528:DC%2BD28XmsVegsbw%3D 16527870
45. P Happonen S Voutilainen TP Tuomainen JT Salonen 2006 Catechol-o-methyltransferase gene polymorphism modifies the effect of coffee intake on incidence of acute coronary events PLoS ONE 1 e117 17205121
46. TR Hartley BH Sung GA Pincomb TL Whitsett MF Wilson WR Lovallo 2000 Hypertension risk status and effect of caffeine on blood pressure Hypertension 36 137 141 1:CAS:528:DC%2BD3cXlslehu78%3D 10904026
47. CF Haskell DO Kennedy KA Wesnes AB Scholey 2005 Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine Psychopharmacology (Berl) 179 813 825 1:CAS:528:DC%2BD2MXjvF2ksbw%3D
48. JM Hettema LA Corey KS Kendler 1999 A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins Drug Alcohol Depend 57 69 78 1:STN:280:DC%2BD3c%2FotlKjtw%3D%3D 10617315
49. C Hohoff JM McDonald BT Baune EH Cook J Deckert H de Wit 2005 Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants Am J Med Genet B Neuropsychiatr Genet 139B 42 44 1:CAS:528:DC%2BD2sXms1yjtLs%3D 16118787
50. ZL Huang WM Qu N Eguchi JF Chen MA Schwarzschild BB Fredholm Y Urade O Hayaishi 2005 Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine Nat Neurosci 8 858 859 1:CAS:528:DC%2BD2MXlvFWjs74%3D 15965471
51. SH Jee J He PK Whelton I Suh MJ Klag 1999 The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials Hypertension 33 647 652 1:STN:280:DyaK1M7kvVWqsA%3D%3D 10024321
52. W Kalow BK Tang 1991 Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities Clin Pharmacol Ther 50 508 519 1:CAS:528:DyaK38XhslGhug%3D%3D 1934864
53. AD Kashuba JS Bertino Jr GL Kearns JS Leeder AW James R Gotschall AN Nafziger 1998 Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping Clin Pharmacol Ther 63 540 551 1:CAS:528:DyaK1cXjvFSlsL4%3D 9630827
54. I Kawachi GA Colditz CB Stone 1994 Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis Br Heart J 72 269 275 1:STN:280:DyaK2M%2FjtlOisw%3D%3D 7946780
55. KS Kendler 1993 Twin studies of psychiatric illness: current status and future directions Arch Gen Psychiatry 50 905 915 1:STN:280: DyaK2c%2FivFCmsg%3D%3D 8215816
56. KS Kendler CA Prescott 1999 Caffeine intake, tolerance, and withdrawal in women: a population-based twin study Am J Psychiatry 156 223 228 1:STN:280:DyaK1M7kt1Kltg%3D%3D 9989558
57. KS Kendler AC Heath NG Martin LJ Eaves 1987 Symptoms of anxiety and symptoms of depression: same genes, different environments? Arch Gen Psychiatry 44 451 457 1:STN:280:DyaL2s3ht1ersw%3D%3D 3579496
58. KS Kendler J Myers CA Prescott 2007 Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence Arch Gen Psychiatry 64 1313 1320 17984400
59. KS Kendler E Schmitt SH Aggen CA Prescott 2008 Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood Arch Gen Psychiatry 65 674 682 18519825
60. IP Kirk PJ Richardson 1994 Adenosine A2a receptor-mediated modulation of striatal GABA and acetylcholine release J Neurochem 62 960 966 1:CAS:528:DyaK2cXhvVersL4%3D 8113816
61. AL Klatsky GD Friedman MA Armstrong 1990 Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk Am J Epidemiol 132 479 488 1:STN:280:DyaK3czlvVWrtA%3D%3D 2389752
62. H Kuribara 1994 Modification by caffeine of the sensitization to methamphetamine and cocaine in terms of ambulation in mice Life Sci 55 933 940 1:CAS:528:DyaK2cXlsVygtLY%3D 8057755
63. M Kurokawa S Shiozaki H Nonaka H Kase J Nakamura Y Kuwana 1996 In vivo regulation of acetylcholine release via adenosine A1 receptor in rat cerebral cortex Neurosci Lett 209 181 184 1:CAS:528:DyaK28Xjt1Slsrs%3D 8736640
64. VS Laitala J Kaprio K Silventoinen 2008 Genetics of coffee consumption and its stability Addiction 103 2054 2061 19469749
65. P Lam CJ Hong SJ Tsai 2005 Association study of A2a adenosine receptor genetic polymorphism in panic disorder Neurosci Lett 378 98 101 1:CAS:528:DC%2BD2MXitlCitbg%3D 15774265
66. JD Lane RA Adcock RB Williams CM Kuhn 1990 Caffeine effects on cardiovascular and neuroendocrine responses to acute psychosocial stress and their relationship to level of habitual caffeine consumption Psychosom Med 52 320 336 1:CAS:528:DyaK3cXlsVGiurc%3D 2195579
67. MA Lee OG Cameron JF Greden 1985 Anxiety and caffeine consumption in people with anxiety disorders Psychiatry Res 15 211 217 1:STN:280: DyaL2M3pvFShsw%3D%3D 3862156
68. M Lee P Flegel J Greden O Cameron 1988 Anxiogenic effects of caffeine on panic and depressed patients Am J Psychiatry 145 632 635 1:STN:280: DyaL1c7ptF2ltQ%3D%3D 3358468
69. A Lelo DJ Birkett RA Robson JO Miners 1986 Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man Br J Clin Pharmacol 22 177 182 1:CAS:528: DyaL28Xls1Cnsbo%3D 3756065
70. PA LeWitt M Guttman JW Tetrud PJ Tuite A Mori P Chaikin NM Sussman 2008 Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005) Ann Neurol 63 295 302 1:CAS:528:DC%2BD1cXlt1Ckt7w%3D 18306243
71. HR Lieberman RJ Wurtman GG Emde C Roberts ILG Coviella 1987 The effects of low doses of caffeine on human performance and mood Psychopharmacology 92 308 312 1:CAS:528:DyaL2sXkvV2ktL0%3D 3114783
72. HR Lieberman WJ Tharion B Shukitt-Hale KL Speckman R Tulley 2002 Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land Psychopharmacology (Berl) 164 250 261 1:CAS:528:DC%2BD38XosFWgtrY%3D
73. WR Lovallo MF Wilson AS Vincent BH Sung BS McKey TL Whitsett 2004 Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption Hypertension 43 760 765 1:CAS:528:DC%2BD2cXit12mtrs%3D 14967827
74. M Luciano KM Kirk AC Heath NG Martin 2005 The genetics of tea and coffee drinking and preference for source of caffeine in a large community sample of Australian twins Addiction 100 1510 1517 16185212
75. M Luciano G Zhu KM Kirk SD Gordon AC Heath GW Montgomery NG Martin 2007 "No thanks, it keeps me awake": the genetics of coffee-attributed sleep disturbance Sleep 30 1378 1386 17969472
76. L Maia A de Mendonca 2002 Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 9 377 382 1:STN:280:DC%2BD38zls12rug%3D%3D 12099922
77. PJ Marangos JP Boulenger J Patel 1984 Effects of chronic caffeine on brain adenosine receptors: regional and ontogenetic studies Life Sci 34 899 907 1:CAS:528:DyaL2cXhtFCqsrc%3D 6321875
78. M Marchi L Raiteri F Risso A Vallarino A Bonfanti A Monopoli E Ongini M Raiteri 2002 Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes Br J Pharmacol 136 434 440 1:CAS:528:DC%2BD38Xks1Kqtbc%3D 12023946
79. MI Martinez-Mir A Probst JM Palacios 1991 Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease Neuroscience 42 697 706 1:CAS:528:DyaK3MXlsFKgtLk%3D 1835521
80. H Merica 1998 Spectral characteristics of sleep EEG in chronic insomnia Eur J Neurosci 10 1826 1834 1:STN:280:DyaK1cvitFOksQ%3D%3D 9751153
81. JR Migliardi JJ Armellino M Friedman DB Gillings WT Beaver 1994 Caffeine as an analgesic adjuvant in tension headache Clin Pharmacol Ther 56 576 586 1:STN:280:DyaK2M%2FktlymtA%3D%3D 7955822
82. JO Miners DJ Birkett 1996 The use of caffeine as a metabolic probe for human drug metabolizing enzymes Gen Pharmacol 27 245 249 1:CAS:528: DyaK28XisVKgtrY%3D 8919637
83. A Monopoli G Lozza A Forlani A Mattavelli E Ongini 1998 Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats NeuroReport 9 3955 3959 1:CAS:528: DyaK1MXjtVChtg%3D%3D 9875735
84. Mosqueda-Garcia R, Robertson D, Robertson RM (1993) The cardiovascular effects of caffeine. In: Garattini S (ed) Caffeine, coffee, and health. Raven, New York, pp 157-176
85. AE Nardi FL Lopes RC Freire AB Veras I Nascimento AM Valença VL de-Melo-Neto GL Soares-Filho AL King DM Araùjo MA Mezzasalma A Rassi WA Zin 2009 Panic disorder and social anxiety disorder subtypes in a caffeine challenge test Psychiatry Res 169 149 153 19698996
86. Neale MC, Cardon LR (1992) Methodology for genetic studies of twins and families. Kluwer, London
87. EP Noble 2000 Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review Eur Psychiatry 15 79 89 1:STN:280:DC%2BD3czptl2qtQ%3D%3D 10881203
88. M Noordzij CS Uiterwaal LR Arends FJ Kok DE Grobbee JM Geleijnse 2005 Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials J Hypertens 23 921 928 1:CAS:528:DC%2BD2MXjt1Knu7Y%3D 15834273
89. ML Nurminen L Niittynen R Korpela H Vapaatalo 1999 Coffee, caffeine and blood pressure: a critical review Eur J Clin Nutr 53 831 839 1:CAS:528:DyaK1MXnvFCjsL0%3D 10556993
90. Y Obase T Shimoda T Kawano S Saeki T S-y K Mitsuta-Izaki H Matsuse M Kinoshita S Kohno 2003 Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma Clin Pharmacol Ther 73 468 474 1:CAS:528:DC%2BD3sXjsVGmtLs%3D 12732846
91. CM Papamichael KA Aznaouridis EN Karatzis KN Karatzi KS Stamatelopoulos G Vamvakou JP Lekakis ME Mavrikakis 2005 Effect of coffee on endothelial function in healthy subjects: the role of caffeine Clin Sci (Lond) 109 55 60 1:CAS:528:DC%2BD2MXntlSnu78%3D
92. ML Perlis H Merica MT Smith DE Giles 2001 Beta EEG activity and insomnia Sleep Med Rev 5 365 376
93. P Popoli D Blum MR Domenici S Burnouf Y Chern 2008 A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's disease Curr Pharm Des 14 1500 1511 1:CAS:528:DC%2BD1cXns1ymsrs%3D 18537673
94. BB Rasmussen TH Brix KO Kyvik K Brøsen 2002 The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors Pharmacogenet Genomics 12 473 478 1:CAS:528:DC%2BD38XmslejtLk%3D
95. JV Retey M Adam R Khatami UF Luhmann HH Jung W Berger HP Landolt 2007 A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep Clin Pharmacol Ther 81 692 698 1:CAS:528:DC%2BD2sXlsFCqsLc%3D 17329997
96. NP Riksen GA Rongen P Smits 2009 Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease Pharmacol Ther 121 185 191 1:CAS:528:DC%2BD1MXitVOks7w%3D 19049813
97. D Robertson D Wade R Workman RL Woosley JA Oates 1981 Tolerance to the humoral and hemodynamic effects of caffeine in man J Clin Invest 67 1111 1117 1:CAS:528:DyaL3MXktVWlsbc%3D 7009653
98. GW Ross RD Abbott H Petrovitch DM Morens A Grandinetti K-H Tung CM Tanner KH Masaki PL Blanchette JD Curb JS Popper LR White 2000 Association of coffee and caffeine intake with the risk of Parkinson disease JAMA 283 2674 2679 1:STN:280:DC%2BD3c3otVSnug%3D%3D 10819950
99. C Sachse J Brockmöller S Bauer I Roots 1999 Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine Br J Clin Pharmacol 47 445 449 1:CAS:528:DyaK1MXivVCmtLo%3D 10233211
100. B Schmidt RS Roberts P Davis LW Doyle KJ Barrington A Ohlsson A Solimano W Tin the Caffeine for Apnea of Prematurity Trial Group 2007 Long-term effects of caffeine therapy for apnea of prematurity N Engl J Med 357 1893 1902 1:CAS:528:DC%2BD2sXht1ymtbjO 17989382
101. NT Shahidi 1967 Acetophenetidin sensitivity Am J Dis Child 113 81 82 1:STN:280:DyaF2s%2FlvFKmsQ%3D%3D 6015912
102. D Shi O Nikodijević KA Jacobson JW Daly 1993 Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain Cell Mol Neurobiol 13 247 261 1:CAS:528:DyaK2cXpsFKmtg%3D%3D 8242688
103. K Silverman RR Griffiths 1992 Low-dose caffeine discrimination and self-reported mood effects in normal volunteers J Exp Anal Behav 57 91 107 1:STN:280:DyaK387ptlOltA%3D%3D 1548451
104. P Smits T Thien A Van 't Laar 1985 The cardiovascular effects of regular and decaffeinated coffee Br J Clin Pharmacol 19 852 854 1:CAS:528: DyaL2MXkvVKlt7g%3D 4027129
105. F Sofi AA Conti AM Gori ML Eliana Luisi A Casini R Abbate GF Gensini 2007 Coffee consumption and risk of coronary heart disease: a meta-analysis Nutr Metab Cardiovasc Dis 17 209 223 1:CAS:528:DC%2BD1cXlslKjsg%3D%3D 17156982
106. GE Swan D Carmelli LR Cardon 1996 The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis J Subst Abuse 8 19 31 1:STN:280:DyaK28zksVWrtw%3D%3D 8743766
107. GE Swan D Carmelli LR Cardon 1997 Heavy consumption of cigarettes, alcohol and coffee in male twins J Stud Alcohol 58 182 190 1:STN:280: DyaK2s3hvVCmuw%3D%3D 9065896
108. JA Swanson JW Lee JW Hopp 1994 Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal Addict Behav 19 229 256 1:STN:280:DyaK2M%2FivVOiuw%3D%3D 7942243
109. EK Tan ZY Lu SMC Fook-Chong E Tan H Shen E Chua Y Yih YY Teo Y Zhao 2006 Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease Am J Med Genet B Neuropsychiatr Genet 141B 634 636 1:CAS:528:DC%2BD2sXmsFaltrg%3D 16823803
110. B Teucher J Skinner PM Skidmore A Cassidy SJ Fairweather-Tait L Hooper MA Roe R Foxall SL Oyston LF Cherkas UC Perks TD Spector AJ MacGregor 2007 Dietary patterns and heritability of food choice in a UK female twin cohort Twin Res Hum Genet 10 734 748 17903115
111. JM Vink AS Staphorsius DI Boomsma 2009 A genetic analysis of coffee consumption in a sample of Dutch twins Twin Res Hum Genet 12 127 131 19335181
112. K Yabuuchi M Kuroiwa T Shuto N Sotogaku GL Snyder H Higashi M Tanaka P Greengard A Nishi 2006 Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum Neuroscience 141 19 25 1:CAS:528:DC%2BD28Xms1emtLk%3D 16750892
113. K Yamada E Hattori M Shimizu A Sugaya H Shibuya T Yoshikawa 2001 Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder J Neural Transm 108 837 848 1:CAS:528: DC%2BD3MXnslKrt7g%3D 11515749
114. NR Zahniser JK Simosky RD Mayfield CA Negri T Hanania GA Larson MA Kelly DK Grandy M Rubinstein MJ Low BB Fredholm 2000 Functional uncoupling of adenosine A2A receptors and reduced response to caffeine in mice lacking dopamine D2 receptors J Neurosci 20 5949 5957 1:CAS:528:DC%2BD3cXlvVCqu7w%3D 10934242